Main content

NICE refuses to approve Lucentis for Diabetic Macular Oedema. 26/07/11

We look at the impact of NICE's decision not to approve a drug used for treating diabetic macular oedema, a condition affecting 50 000 people in the UK. Plus more from Sight Vilage, the exhibition which showcases the latest technology for blind and partially sighted people.

Available now

20 minutes

Last on

Tue 26 Jul 2011 20:40
麻豆社 Radio 4

More episodes

Previous

Sight Village technology - we review the latest gadgets. 19/07/2011

Next

Peter White talks to Maggie Rosen about her partial sight + Can't See Will Cook

See all episodes from In Touch

Broadcast

  • Tue 26 Jul 2011 20:40
    麻豆社 Radio 4

Download this programme

Listen anytime or anywhere. Subscribe to this programme or download individual episodes.

Podcast

  • In Touch

    News, views and information for people who are blind or partially sighted